Dear ,

Here are the latest Foregen updates:

Pilot Recellularization Test

We are pleased to share that we have successfully completed our pilot recellularization experiments. Chief Bioengineer Ján Kováč has confirmed that our decellularized scaffolds are non-toxic and provide a viable environment for new growth, as verified through confocal transmission microscopy across approximately 50 different samples. The study demonstrated that multiple cell types—including fibroblasts, keratinocytes, and stem cells—successfully attached to the scaffold and began proliferating within a 48-hour window. These results provide the confirmation needed to move onto full-scale recellularization protocols, which will be the final activities of Milestone 3. This brings us one step closer to our clinical goals. Read more!

Inside the Lab: Episode 3

The third episode of our "Inside the Lab" series is now live! In this latest installment, we take you behind the scenes to view the specialized equipment and advanced techniques that make our decellularization and recellularization protocols possible. Chief Bioengineer Ján Kováč and Chief Science Officer William Musa showcase our bioreactor. You can watch the full episode on our YouTube channel.

Community Support

With your generous donations, we raised $16,777 last month! This enables us to continue our critical mission and helps bring us closer to our clinical goals, each and every day.

Thank you for standing with us as we conduct this ever important preclinical research. We couldn't do this without you.

Sincerely,

Ryan Jones
Chief Operations Officer
Foregen